ArticleThe breast journal2024

The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer.

Ting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.